ATM and cancer: The above mentioned data suggest an attractive complementary strategy by which we might prevent or halt cancer that is functionally compatible with activation of the ATM pathway: the senescence process is dependent on ATM signaling, and senescence can be bypassed or suppressed by microinjection of kinase-dead constructs of ATM or by treatment with ATM inhibitors [42-46].